+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thromboresistant Coatings Market - Global Forecast 2026-2032- Product Image
Thromboresistant Coatings Market - Global Forecast 2026-2032- Product Image
Sale

Thromboresistant Coatings Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6136533
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Thromboresistant Coatings Market is projected to reach USD 749.34 Million in 2026. It is expected to continue growing at a CAGR of 10.37%, reaching USD 1.35 Billion by 2032.

Thromboresistant Coatings: Executive Overview

Thromboresistant coatings are surface technologies designed to reduce blood clot formation and platelet adhesion on blood-contacting medical devices. Their relevance spans cardiovascular, neurovascular, extracorporeal, and other interventional applications where surface-blood interactions influence safety, device performance, and clinical usability. Development priorities increasingly combine hemocompatibility with durability, sterilization tolerance, manufacturability, and compatibility with minimally invasive device designs.

How Device Design and Regulation Are Reshaping Coatings

The landscape is shifting from single-function surface treatment toward multifunctional coating systems that address thrombosis, inflammation, biofouling, and mechanical wear together. Device miniaturization, longer implantation or circulation periods, and more complex geometries are raising demands for uniform coverage and reliable adhesion. Regulatory scrutiny is also encouraging stronger evidence on extractables, particulates, degradation behavior, sterilization effects, and coating performance throughout the device lifecycle.

Artificial Intelligence Accelerates Formulation and Quality Decisions

Artificial intelligence can support thromboresistant-coating development by linking formulation variables, surface characterization, flow conditions, and biological test outcomes. Machine-learning models may help prioritize experiments, identify relationships among coating chemistry and durability, and flag process conditions associated with defects. In manufacturing, computer vision and process analytics can improve inspection and consistency, but model outputs require validated datasets, traceable controls, and human review appropriate to regulated medical-device production.

Regional Insights Across the Global Development Landscape

North America combines advanced cardiovascular-device research with demanding regulatory and clinical-evidence expectations. Europe emphasizes biocompatibility, lifecycle documentation, and harmonized medical-device compliance, while Asia-Pacific benefits from expanding device manufacturing, engineering capabilities, and clinical infrastructure. Latin America presents opportunities linked to improving access to interventional care but requires attention to procurement, reimbursement, and local regulatory variation. The Middle East is supported by investment in specialized healthcare systems, whereas Africa’s adoption is shaped by affordability, supply continuity, training, and infrastructure. Across all regions, localized validation and dependable sterilization and logistics pathways remain important.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets are relevant to regional manufacturing networks and expanding healthcare capacity, with regulatory coordination and technology transfer remaining practical priorities. BRICS economies reflect diverse device ecosystems, research capabilities, and public-health needs, making scalable production and locally appropriate evidence important. The European Union places strong emphasis on conformity assessment, clinical documentation, and post-market surveillance. G7 economies generally support sophisticated R&D, quality systems, and advanced interventional care. GCC countries are investing in high-acuity healthcare and value supplier reliability, while NATO members share strategic interest in resilient medical supply chains and dependable technologies for complex care settings.

Country Insights: Distinct Regulatory and Manufacturing Contexts

Australia and Canada combine specialized healthcare demand with structured regulatory pathways. Brazil and Mexico offer important Latin American clinical and manufacturing contexts, while the United States remains a major center for device innovation, clinical research, and regulatory validation. China, India, Japan, and South Korea bring substantial engineering, manufacturing, and hospital capabilities, although regulatory and procurement requirements differ. In Europe, France, Germany, Italy, Spain, and the United Kingdom each contribute clinical expertise and industrial capacity within distinct national implementation environments. Russia presents a separate regulatory and supply-chain context requiring careful assessment of local access, evidence, and sourcing conditions.

Actions for Leaders: Build Evidence, Resilience, and Coating Performance

Industry leaders should align coating development with the intended device, blood-contact duration, flow environment, sterilization method, and complete manufacturing route. They should establish early test plans covering hemocompatibility, adhesion, abrasion, degradation, particulates, and shelf-life behavior, then connect those results to clinically relevant use conditions. Investment in scalable deposition and inspection processes can reduce variability, while supplier qualification and regional contingency planning can strengthen continuity. Leaders should also govern artificial-intelligence tools through validated data, documented decision logic, cybersecurity controls, and post-deployment monitoring.

Research Methodology for the Thromboresistant-Coatings Assessment

This executive summary uses a structured qualitative assessment of thromboresistant-coating applications, technology requirements, regulatory considerations, regional environments, and country-level industry conditions. The analysis organizes findings across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, and incorporates the specified ASEAN, BRICS, European Union, G7, GCC, and NATO groupings. Country interpretation considers healthcare capacity, device manufacturing, research activity, regulatory context, and supply-chain conditions. Claims are limited to broadly supportable industry characteristics; no market estimates, shares, forecasts, or company-specific conclusions are included.

Conclusion: Durable Hemocompatibility Is the Strategic Differentiator

Thromboresistant coatings are becoming an integrated component of medical-device design rather than an isolated surface feature. The strongest development strategies will balance hemocompatibility with mechanical durability, process control, sterilization resilience, regulatory evidence, and dependable supply. Regional and country conditions will shape adoption differently, but disciplined validation and responsible use of digital and artificial-intelligence tools can help leaders improve coating consistency and support safer blood-contacting devices.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Thromboresistant Coatings Market, by Coating Technology
7.1. Introduction
7.2. Heparin Coatings
7.3. Nitric Oxide Releasing Coatings
7.3.1. Diazeniumdiolate Donors
7.3.2. S-Nitrosothiols
7.4. Phosphorylcholine Coatings
8. Thromboresistant Coatings Market, by Material Type
8.1. Introduction
8.2. Inorganic Materials
8.2.1. Silicon Oxide
8.2.2. Titanium Oxide
8.3. Natural Polymers
8.3.1. Chitosan
8.3.2. Heparin
8.4. Synthetic Polymers
8.4.1. Polyethylene Glycol
8.4.2. Polyurethane
9. Thromboresistant Coatings Market, by Application
9.1. Introduction
9.2. Extracorporeal Devices
9.2.1. Blood Oxygenators
9.2.2. Cardiopulmonary Bypass Circuits
9.2.3. Dialysis Equipment
9.3. Intracorporeal Devices
9.3.1. Heart Valves
9.3.2. Stents
9.3.3. Vascular Grafts
10. Thromboresistant Coatings Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.3. Hospitals
10.4. Research Laboratories
11. Thromboresistant Coatings Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Thromboresistant Coatings Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Thromboresistant Coatings Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Alchemia Oncology Limited
15.3. AST Products, Inc.
15.4. Biocoat, Incorporated
15.5. Boston Scientific Corporation
15.6. Corline Biomedical AB
15.7. Covalon Technologies Ltd.
15.8. Hemolens Clinical Sp. z o.o.
15.9. Hemoteq AG
15.10. Hydromer, Inc.
15.11. Interface Biologics, Inc.
15.12. Johnson & Johnson
15.13. LivaNova PLC
15.14. Medtronic plc
15.15. Merit Medical Systems, Inc.
15.16. Quest Medical, Inc.
15.17. Royal DSM N.V.
15.18. SurModics, Inc.
15.19. Terumo Corporation
15.20. Trinseo PLC
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Thromboresistant Coatings Market, Years Considered for the Study
FIGURE 2. Global Thromboresistant Coatings Market, Research Design
FIGURE 3. Global Thromboresistant Coatings Market, Research Framework
FIGURE 4. Global Thromboresistant Coatings Market, Data Triangulation
FIGURE 5. Global Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Thromboresistant Coatings Market Size, by Coating Technology, 2025 vs 2032 (%)
FIGURE 7. Global Thromboresistant Coatings Market Size, by Coating Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Thromboresistant Coatings Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 9. Global Thromboresistant Coatings Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Thromboresistant Coatings Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Thromboresistant Coatings Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Thromboresistant Coatings Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Thromboresistant Coatings Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Thromboresistant Coatings Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Thromboresistant Coatings Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Thromboresistant Coatings Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Thromboresistant Coatings Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Thromboresistant Coatings Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Thromboresistant Coatings Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Thromboresistant Coatings Market Segmentation & Coverage
TABLE 2. Global Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 3. Global Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 4. Global Heparin Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Heparin Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Heparin Coatings Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nitric Oxide Releasing Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nitric Oxide Releasing Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nitric Oxide Releasing Coatings Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Diazeniumdiolate Donors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Diazeniumdiolate Donors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Diazeniumdiolate Donors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global S-Nitrosothiols Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global S-Nitrosothiols Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global S-Nitrosothiols Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Phosphorylcholine Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Phosphorylcholine Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Phosphorylcholine Coatings Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 20. Global Inorganic Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Inorganic Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Inorganic Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Silicon Oxide Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Silicon Oxide Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Silicon Oxide Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Titanium Oxide Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Titanium Oxide Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Titanium Oxide Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Natural Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Natural Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Natural Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Chitosan Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Chitosan Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Chitosan Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Heparin Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Heparin Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Heparin Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Synthetic Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Synthetic Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Synthetic Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Polyethylene Glycol Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Polyethylene Glycol Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Polyethylene Glycol Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Polyurethane Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Polyurethane Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Polyurethane Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. Global Extracorporeal Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Extracorporeal Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Extracorporeal Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Blood Oxygenators Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Blood Oxygenators Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Blood Oxygenators Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Cardiopulmonary Bypass Circuits Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cardiopulmonary Bypass Circuits Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cardiopulmonary Bypass Circuits Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Dialysis Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Dialysis Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Dialysis Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Intracorporeal Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Intracorporeal Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Intracorporeal Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Heart Valves Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Heart Valves Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Heart Valves Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Vascular Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Vascular Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Vascular Grafts Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Global Ambulatory Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Ambulatory Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Ambulatory Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. North America Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. North America Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 96. North America Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 97. North America Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 98. North America Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 99. North America Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 100. North America Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 101. North America Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. North America Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 103. North America Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 104. North America Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Latin America Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Latin America Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 107. Latin America Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 108. Latin America Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 109. Latin America Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 110. Latin America Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 111. Latin America Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 112. Latin America Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Latin America Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 114. Latin America Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 115. Latin America Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Europe Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Europe Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 118. Europe Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 119. Europe Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 120. Europe Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 121. Europe Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 122. Europe Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 123. Europe Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. Europe Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 125. Europe Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 126. Europe Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Middle East Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Middle East Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 129. Middle East Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 130. Middle East Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 131. Middle East Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 132. Middle East Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 133. Middle East Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 134. Middle East Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Middle East Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 136. Middle East Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 137. Middle East Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Africa Thromboresistant Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Africa Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 140. Africa Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 141. Africa Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 142. Africa Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 143. Africa Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 144. Africa Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 145. Africa Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Africa Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 147. Africa Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 148. Africa Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Global Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. ASEAN Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 152. ASEAN Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 153. ASEAN Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 154. ASEAN Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 155. ASEAN Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 156. ASEAN Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 157. ASEAN Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. ASEAN Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 159. ASEAN Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 160. ASEAN Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. GCC Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. GCC Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 163. GCC Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 164. GCC Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 165. GCC Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 166. GCC Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 167. GCC Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 168. GCC Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. GCC Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 170. GCC Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 171. GCC Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. European Union Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. European Union Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 174. European Union Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 175. European Union Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 176. European Union Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 177. European Union Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 178. European Union Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 179. European Union Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. European Union Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 181. European Union Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 182. European Union Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. BRICS Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. BRICS Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 185. BRICS Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 186. BRICS Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 187. BRICS Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 188. BRICS Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 189. BRICS Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 190. BRICS Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. BRICS Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 192. BRICS Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 193. BRICS Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. G7 Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. G7 Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 196. G7 Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 197. G7 Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 198. G7 Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 199. G7 Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 200. G7 Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 201. G7 Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. G7 Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 203. G7 Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 204. G7 Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. NATO Thromboresistant Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. NATO Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 207. NATO Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 208. NATO Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 209. NATO Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 210. NATO Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 211. NATO Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 212. NATO Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. NATO Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 214. NATO Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 215. NATO Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Global Thromboresistant Coatings Market Size, by Country, 2017-2032 (USD Million)
TABLE 217. United States Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 218. United States Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 219. United States Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 220. United States Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 221. United States Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 222. United States Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 223. United States Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 224. United States Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. United States Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 226. United States Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 227. United States Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Canada Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 229. Canada Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 230. Canada Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 231. Canada Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 232. Canada Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 233. Canada Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 234. Canada Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 235. Canada Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Canada Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 237. Canada Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 238. Canada Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Mexico Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 240. Mexico Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 241. Mexico Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 242. Mexico Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 243. Mexico Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 244. Mexico Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 245. Mexico Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 246. Mexico Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. Mexico Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 248. Mexico Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 249. Mexico Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Brazil Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 251. Brazil Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 252. Brazil Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 253. Brazil Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 254. Brazil Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 255. Brazil Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 256. Brazil Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 257. Brazil Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Brazil Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 259. Brazil Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 260. Brazil Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. United Kingdom Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 262. United Kingdom Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 263. United Kingdom Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 264. United Kingdom Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 265. United Kingdom Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 266. United Kingdom Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 267. United Kingdom Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 268. United Kingdom Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. United Kingdom Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 270. United Kingdom Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 271. United Kingdom Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Germany Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 273. Germany Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 274. Germany Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 275. Germany Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 276. Germany Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 277. Germany Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 278. Germany Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 279. Germany Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Germany Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 281. Germany Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 282. Germany Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. France Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 284. France Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 285. France Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 286. France Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 287. France Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 288. France Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 289. France Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 290. France Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. France Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 292. France Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 293. France Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Russia Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 295. Russia Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 296. Russia Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 297. Russia Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 298. Russia Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 299. Russia Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 300. Russia Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 301. Russia Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. Russia Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 303. Russia Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 304. Russia Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Italy Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 306. Italy Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 307. Italy Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 308. Italy Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 309. Italy Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 310. Italy Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 311. Italy Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 312. Italy Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. Italy Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 314. Italy Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 315. Italy Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. Spain Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 317. Spain Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 318. Spain Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 319. Spain Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 320. Spain Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 321. Spain Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 322. Spain Thromboresistant Coatings Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 323. Spain Thromboresistant Coatings Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. Spain Thromboresistant Coatings Market Size, by Extracorporeal Devices, 2017-2032 (USD Million)
TABLE 325. Spain Thromboresistant Coatings Market Size, by Intracorporeal Devices, 2017-2032 (USD Million)
TABLE 326. Spain Thromboresistant Coatings Market Size, by End User, 2017-2032 (USD Million)
TABLE 327. China Thromboresistant Coatings Market Size, 2017-2032 (USD Million)
TABLE 328. China Thromboresistant Coatings Market Size, by Coating Technology, 2017-2032 (USD Million)
TABLE 329. China Thromboresistant Coatings Market Size, by Nitric Oxide Releasing Coatings, 2017-2032 (USD Million)
TABLE 330. China Thromboresistant Coatings Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 331. China Thromboresistant Coatings Market Size, by Inorganic Materials, 2017-2032 (USD Million)
TABLE 332. China Thromboresistant Coatings Market Size, by Natural Polymers, 2017-2032 (USD Milli

Companies Mentioned

  • Abbott Laboratories
  • Alchemia Oncology Limited
  • AST Products, Inc.
  • Biocoat, Incorporated
  • Boston Scientific Corporation
  • Corline Biomedical AB
  • Covalon Technologies Ltd.
  • Hemolens Clinical Sp. z o.o.
  • Hemoteq AG
  • Hydromer, Inc.
  • Interface Biologics, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Quest Medical, Inc.
  • Royal DSM N.V.
  • SurModics, Inc.
  • Terumo Corporation
  • Trinseo PLC

Related Topics

Related Reports

Hydrophobic Coatings Market Report 2026 - Product Image

Hydrophobic Coatings Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Anti-Reflective Coatings Market - Global Forecast 2026-2032 - Product Image

Anti-Reflective Coatings Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Global Ceramic Coatings Market Overview, 2023-28 - Product Image

Global Ceramic Coatings Market Overview, 2023-28

  • Report
  • 108 Pages
  • Global
From
Precision Medical Coating Market - Global Forecast 2026-2032 - Product Image

Precision Medical Coating Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Medical Heparin Coating Market Summary 2026: Industry Trends, Innovations, and Competitive Landscape - Product Image

Medical Heparin Coating Market Summary 2026: Industry Trends, Innovations, and Competitive Landscape

  • Report
  • 133 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.